TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ProboNova Medical Innovations AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13
|
33
|
20 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-59
|
-7
|
-1 |
EBITDA |
-60
|
-7
|
-1 |
Total assets |
49
|
31
|
66 |
Current assets |
49
|
31
|
66 |
Current liabilities |
15
|
0
|
30 |
Equity capital |
34
|
31
|
36 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
69.4%
|
100%
|
54.5% |
Turnover per employee |
13
|
33
|
20 |
Profit as a percentage of turnover |
-453.8%
|
-21.2%
|
-5.0% |
Return on assets (ROA) |
-120.4%
|
-22.6%
|
-1.5% |
Current ratio | 326.7% | 220.0% | |
Return on equity (ROE) |
-173.5%
|
-22.6%
|
-2.8% |
Change turnover |
-19
|
15
|
-4 |
Change turnover % |
-59%
|
81%
|
-18% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.